Pieris Pharmaceuticals, Inc. Financial Ratios — PIRS Stock

Profitability (USD)

	2013 Y	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	1.82	-0.43	-90.08	-50.38	-66.07	-25.4	-21.82	-18.04	-30.26	-35.38	-26.72	- -
Return on Capital (%)	- -	-2.19	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	20.67	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	100	- -	100	100	100	100	100	100	100	100	100	- -
EBITDA Margin (%)	- -	9.5	- -	-150.65	-521.83	-384.12	-56.28	-103.99	-56.43	-108.43	-145.71	-125.55	- -
Operating Margin (%)	- -	5.61	- -	-158.74	-533.85	-390.31	-57.74	-105.94	-58.68	-115.68	-153.24	-136.29	- -
Incremental Operating Margin (%)	- -	5.61	5.76	- -	- -	- -	- -	- -	- -	- -	- -	- -	-136.29
Pretax Margin (%)	- -	0.67	- -	-217.22	-540.63	-388.22	-65.46	-93.01	-55.03	-126.41	-145.58	-128.47	- -
Profit Margin (%)	- -	0.67	- -	-217.22	-548.58	-391	-69.82	-91.93	-55.03	-126.97	-145.58	-128.47	- -
Net Income to Common Margin (%)	- -	0.67	- -	-217.22	-548.58	-391	-69.82	-91.93	-61.15	-126.97	-145.58	-128.47	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	10	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	- -	5	- -	1	- -	- -	- -	- -	16	17	15	13	- -
ST Debt	- -	- -	- -	1	- -	- -	- -	- -	1	1	1	1	- -
LT Debt	- -	5	- -	- -	- -	- -	- -	- -	15	16	14	12	- -
Total Debt/EBITDA	-1.73	5.06	-0.03	-0.19	- -	- -	- -	- -	-0.62	-0.53	-0.33	-0.4	- -
Net Debt/EBITDA	17.25	1.13	0.68	2.52	2.19	1.31	2.66	2.47	2.38	2.22	2.57	1.19	- -
Total Debt/EBIT	-1.73	8.58	-0.03	-0.18	- -	- -	- -	- -	-0.6	-0.5	-0.31	-0.37	- -
Net Debt/EBIT	17.25	1.92	0.68	2.39	2.15	1.29	2.6	2.43	2.29	2.08	2.45	1.09	- -
EBITDA to Interest Expense	- -	1.9	- -	-2.57	-72.43	9,654.31	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	1.8	- -	-2.67	-75.79	9,895.69	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	1.12	- -	-2.71	-74.09	9,809.91	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	3	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	90.88	-768.8	-88.76	-300.94	-235.13	-292.68	-115.78	-104.01	-123.41	-201.27	-167.41	-304.06	- -
Long-Term Debt/Equity (%)	- -	776.73	- -	- -	- -	- -	- -	- -	30.15	51.35	27.27	43.84	- -
Long-Term Debt/Capital (%)	- -	-8.88	- -	- -	- -	- -	- -	- -	-9.81	-8.2	-5.72	-4.42	- -
Long-Term Debt/Total Assets (%)	- -	62.44	- -	- -	- -	- -	- -	- -	10.97	15.17	9.01	12.82	- -
Total Debt/Equity (%)	10.03	812.03	4.73	7.06	- -	- -	- -	- -	31.58	54.67	29.34	46.92	- -
Total Debt/Capital (%)	9.12	-9.28	-5.04	-1.97	- -	- -	- -	- -	-10.27	-8.73	-6.15	-4.73	- -
Total Debt/Total Assets (%)	9.12	65.28	4.26	5.81	- -	- -	- -	- -	11.49	16.15	9.7	13.72	- -
Net Debt to Equity	-100	181.37	-106.49	-95.54	-94.28	-116.37	-328.75	-187.47	-121.24	-227.02	-232.02	-138.33	- -
Net Debt/Capital (%)	- -	-1.93	51.89	20.73	26.88	22.24	23.95	33.74	28.28	26.6	32.72	12.23	- -
EBITDA	- -	1	- -	-7	-13	-22	-14	-30	-26	-32	-46	-33	- -
EBITDA-CapEx	- -	1	- -	-7	-14	-23	-16	-32	-29	-35	-47	-34	- -
Operating Income (Loss)	- -	1	- -	-7	-14	-23	-15	-31	-27	-34	-48	-35	- -

Liquidity (USD)

API Chat

	2013 Y	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	10.97	2.09	9.91	5.25	10.49	3.5	1.59	2.66	3.86	3.18	2.33	1.62	- -
Current Ratio	10.97	2.73	9.91	5.63	11.32	3.9	1.96	2.82	4.26	3.42	2.52	2.01	- -
Quick Ratio	10.97	2.4	9.91	5.26	10.49	3.51	1.93	2.72	4.11	3.26	2.39	1.92	- -
CFO/Avg Current Liab	- -	-3.48	-0.02	-2.88	-4.02	-2.57	1.84	-0.02	-1.4	-1.87	-0.21	-1.38	- -
Common Equity/Total Assets	90.88	-768.8	-88.76	-300.94	-235.13	-292.68	-115.78	-104.01	-123.41	-201.27	-167.41	-304.06	- -
Long-Term Debt/Equity (%)	- -	776.73	- -	- -	- -	- -	- -	- -	30.15	51.35	27.27	43.84	- -
Long-Term Debt/Capital (%)	- -	-8.88	- -	- -	- -	- -	- -	- -	-9.81	-8.2	-5.72	-4.42	- -
Long-Term Debt/Total Assets (%)	- -	62.44	- -	- -	- -	- -	- -	- -	10.97	15.17	9.01	12.82	- -
Total Debt/Equity (%)	10.03	812.03	4.73	7.06	- -	- -	- -	- -	31.58	54.67	29.34	46.92	- -
Total Debt/Capital (%)	9.12	-9.28	-5.04	-1.97	- -	- -	- -	- -	-10.27	-8.73	-6.15	-4.73	- -
Total Debt/Total Assets (%)	9.12	65.28	4.26	5.81	- -	- -	- -	- -	11.49	16.15	9.7	13.72	- -
CFO/Total Liabilities	-57.81	-45.97	-1,340.04	-131.53	-450.27	-146.28	53.87	-1.05	-58.46	-62.04	-7.45	-88.71	- -
CFO/CapEx	- -	-62.19	- -	-18.94	-20.47	-25.69	25.51	-0.63	-21.31	-16.84	-8.07	-57.57	- -
Altman's Z-Score	0.84	-8.65	-5.59	-4.2	13.22	-1.67	0.82	-0.39	-0.06	-1.89	-1.15	-4.06	- -

Working Capital (USD)

API Chat

	2013 Y	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	41.01	- -	- -	- -	204.6	3.24	3.19	9.76	6.91	12.52	5.68	- -
Days Sales Outstanding	- -	8.9	- -	- -	- -	1.78	112.66	114.43	37.42	52.86	29.15	64.28	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	- -	- -	79	59	332	141	183	136	244	77	16
- Cash & Cash Equivalents	- -	4	- -	18	29	29	38	75	62	70	118	39	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	5	- -	1	- -	- -	- -	- -	16	17	15	13	- -
Enterprise Value	- -	1	- -	-17	49	29	259	13	95	83	141	31	16
Total Capital	- -	-51	- -	-65	-80	-103	-120	-147	-158	-194	-242	-277	- -
Total Debt/Capital (%)	9.12	-9.28	-5.04	-1.97	- -	- -	- -	- -	-10.27	-8.73	-6.15	-4.73	- -
Total Debt / EV	-0.1	4.48	-0.04	-0.07	- -	- -	- -	- -	0.17	0.21	0.11	0.42	- -
EV/Sales	- -	0.11	- -	- -	19.28	5.02	10.25	0.45	2.06	2.82	4.49	1.2	- -
EV/EBITDA	- -	1.13	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	1.92	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	5.21	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	5.01	20.71	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	79	59	332	141	183	136	244	77	16
Diluted Enterprise Value	- -	1	- -	-17	49	29	294	66	137	83	141	52	16
EV per Share	- -	6.12	- -	- -	114.93	56.12	471.74	19.73	150.64	121.48	174.9	33.51	14.56
TTM Sales	- -	10	- -	5	3	6	25	29	46	29	31	26	- -
TTM EBITDA	- -	1	- -	-7	-13	-22	-14	-30	-26	-32	-46	-33	- -
TTM Operating Income	- -	1	- -	-7	-14	-23	-15	-31	-27	-34	-48	-35	- -
TTM Cash Flow to Firm	- -	-3	- -	-2	-13	-14	50	-1	-52	-46	-8	-60	- -
TTM Free Cash Flow to Firm	- -	-3	- -	-2	-12	-14	52	1	-50	-43	-7	-59	- -

Multiples (USD)

API Chat

	2013 Y	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Free Cash Flow	- -	- -	- -	- -	-6.52	-4.24	6.41	223.41	-3.66	-3.16	-36.36	-1.31	- -
EV/EBIT	- -	1.92	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	1	- -	-17	49	29	259	13	95	83	141	31	16
Low Price	- -	- -	- -	- -	123.15	100.8	110.4	191.2	195.2	128	136	67.71	10.89
EV/Sales	- -	0.11	- -	- -	19.28	5.02	10.25	0.45	2.06	2.82	4.49	1.2	- -
EV/EBITDA	- -	1.13	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	-6.75	-3.15	-10.61	-11.38	-6.73	-4.21	-4.9	-4.54	- -
Price/Earnings High	- -	- -	- -	- -	-10.76	-4.54	-19.27	-19.34	-10.81	-6.29	-8.68	-9.08	- -
Price/Earnings Low	- -	- -	- -	- -	-3.77	-2.31	-3.44	-4.74	-4.36	-2.34	-2.4	-1.89	- -
Price/Book Value	- -	- -	- -	- -	-0.99	-0.57	-2.76	-0.96	-1.05	-0.64	-0.95	-0.27	- -
Price/Book Value Average	- -	- -	- -	- -	-1.19	-0.7	-1.56	-2.07	-1.09	-0.74	-0.87	-0.52	- -
Price/Book Value High	- -	- -	- -	- -	-1.9	-1.01	-2.83	-3.52	-1.76	-1.11	-1.54	-1.04	- -
Price/Book Value Low	- -	- -	- -	- -	-0.66	-0.51	-0.5	-0.86	-0.71	-0.41	-0.43	-0.22	- -
Price/Tangible Book Value	- -	- -	- -	- -	2.53	2.32	28.79	3.54	3.57	4.39	4.81	2.76	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	3.05	2.85	16.25	7.62	3.71	5.05	4.41	5.41	- -
Price/Tangible Book Value High	- -	- -	- -	- -	4.86	4.1	29.51	12.96	5.95	7.55	7.82	10.82	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	1.7	2.08	5.26	3.18	2.41	2.81	2.16	2.25	- -
Price/Sales	- -	- -	- -	- -	30.73	10.05	13.12	4.85	3.96	4.64	7.77	2.98	- -
Price/Sales Average	- -	- -	- -	- -	37.03	12.31	7.41	10.46	4.11	5.35	7.13	5.84	- -
Price/Sales High	- -	- -	- -	- -	59.05	17.74	13.45	17.78	6.61	7.99	12.63	11.67	- -
Price/Sales Low	- -	- -	- -	- -	20.66	9.01	2.4	4.36	2.67	2.97	3.49	2.42	- -
Price/Cash Flow	- -	- -	- -	- -	-6.2	-4.07	6.67	-132.45	-3.49	-2.97	-31.85	-1.29	- -
Price/Cash Flow Average	- -	- -	- -	- -	-7.47	-4.99	3.76	-285.51	-3.63	-3.42	-29.23	-2.52	- -
Price/Cash Flow High	- -	- -	- -	- -	-11.91	-7.19	6.83	-485.5	-5.83	-5.1	-51.82	-5.04	- -
Price/Cash Flow Low	- -	- -	- -	- -	-4.17	-3.65	1.22	-119.01	-2.35	-1.9	-14.33	-1.05	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	-7.85	-5.19	3.62	481.57	-3.81	-3.63	-33.36	-2.57	- -
Price/Free Cash Flow High	- -	- -	- -	- -	-12.52	-7.48	6.58	818.89	-6.11	-5.43	-59.15	-5.13	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	-4.38	-3.8	1.17	200.73	-2.47	-2.02	-16.35	-1.07	- -
EV/Sales Average	- -	0.11	- -	- -	25.57	7.28	5.91	7.89	3.12	3.52	3.85	4.85	- -
EV/Sales High	- -	0.11	- -	- -	47.6	12.71	11.95	15.21	5.61	6.17	9.36	10.68	- -
EV/Sales Low	- -	0.11	- -	- -	9.21	3.98	0.9	1.79	1.67	1.15	0.22	1.44	- -
EV/EBITDA Average	17.25	1.13	0.68	2.52	-4.9	-1.89	-10.5	-7.58	-5.53	-3.25	-2.64	-3.86	- -
EV/EBITDA High	17.25	1.13	0.68	2.52	-9.12	-3.31	-21.24	-14.63	-9.94	-5.69	-6.42	-8.51	- -
EV/EBITDA Low	17.25	1.13	0.68	2.52	-1.76	-1.04	-1.6	-1.72	-2.97	-1.06	-0.15	-1.15	- -
EV/EBIT Average	17.25	1.92	0.68	2.39	-4.79	-1.86	-10.23	-7.44	-5.31	-3.04	-2.51	-3.56	- -
EV/EBIT High	17.25	1.92	0.68	2.39	-8.92	-3.26	-20.7	-14.36	-9.56	-5.33	-6.11	-7.84	- -
EV/EBIT Low	17.25	1.92	0.68	2.39	-1.72	-1.02	-1.56	-1.69	-2.85	-0.99	-0.14	-1.06	- -
Last Price	- -	- -	- -	- -	183.2	112.42	604	212.8	289.6	200	302.4	83.2	14.56
High Price	- -	- -	- -	- -	352	198.4	619.2	780	483.2	344	492	326.04	157.6
Enterprise Value Average	- -	1	- -	-17	66	42	149	229	144	103	121	126	61
Enterprise Value High	- -	1	- -	-17	122	74	302	443	260	181	294	277	177
Enterprise Value Low	- -	1	- -	-17	24	23	23	52	77	34	7	37	12

	2013 Y	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	- -	- -	- -	- -	- -	1	1	1	1	1	1	1	1
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	1	1	1	1	1	1
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	1	1	1	1	1	1
Revenue per Share	- -	57.01	- -	26.15	5.96	11.18	46.03	43.86	73.13	43.06	38.94	27.94	- -
EBITDA per Share	- -	5.42	-0.09	-39.4	-31.11	-42.96	-25.9	-45.61	-41.27	-46.69	-56.74	-35.08	- -
Operating Income per Share	- -	3.2	-0.09	-41.51	-31.82	-43.65	-26.58	-46.47	-42.91	-49.81	-59.67	-38.07	- -
Basic EPS, GAAP	- -	0.38	-0.09	-56.8	-32.7	-43.73	-32.14	-40.32	-44.72	-54.67	-56.69	-35.89	- -
Basic EPS from Cont Ops	- -	0.38	-0.09	-56.8	-32.7	-43.73	-32.14	-40.32	-40.25	-54.67	-56.69	-35.89	- -
Diluted EPS, GAAP	- -	0.38	-0.09	-56.8	-32.7	-43.73	-32.14	-40.32	-44.72	-54.67	-56.69	-35.89	- -
Diluted EPS from Cont Ops	- -	0.38	-0.09	-56.8	-32.7	-43.73	-32.14	-40.32	-40.25	-54.67	-56.69	-35.89	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-17.75	-0.09	-29.21	-29.55	-27.59	90.6	-1.61	-82.91	-67.39	-9.49	-64.64	- -
Free Cash Flow per Basic Share	- -	-18.04	-0.09	-30.76	-31	-28.67	87.05	-4.17	-86.8	-71.4	-10.67	-65.76	- -
Cash & Equivalents per Share	0.03	21.29	0.06	106.54	68.27	56.3	132.26	193.07	164.59	103.43	145.96	63.82	- -
Book Value per Share	0.03	-322.84	-0.06	-379.33	-185.68	-196.81	-219.01	-221.57	-275.15	-310.35	-318.62	-313.16	- -
Tangible Book Value per Share	0.03	3.38	0.06	103.84	72.41	48.38	20.98	60.19	81.15	45.56	62.91	30.12	- -

Pieris Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)